Interim analysis of an open-label randomized controlled trial evaluating nasal irrigations in non-hospitalized patients with coronavirus disease 2019

被引:30
|
作者
Kimura, Kyle S. [1 ]
Freeman, Michael H. [1 ]
Wessinger, Bronson C. [2 ]
Gupta, Veerain [2 ]
Sheng, Quanhu [3 ]
Huang, Li Ching [3 ]
Von Wahlde, Kate [1 ]
Das, Suman R. [1 ,4 ]
Chowdhury, Naweed I. [1 ]
Turner, Justin H. [1 ]
机构
[1] Vanderbilt Univ, Med Ctr, Dept Otolaryngol Head & Neck Surg, 1215 21st Ave South,Suite 7209, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA
[3] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN USA
[4] Vanderbilt Univ, Sch Med, Dept Med, Div Microbiol & Infect Dis, Nashville, TN 37212 USA
关键词
saline; coronavirus; COVID-19; irrigation; nasal;
D O I
10.1002/alr.22703
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
引用
收藏
页码:1325 / 1328
页数:4
相关论文
共 50 条
  • [1] Evaluating the therapeutic effects of isotretinoin on patients with coronavirus disease 2019 (COVID-19): A controlled open-label clinical trial
    Shirvani, Maria
    Vaziri, Siavash
    Akrami, Mohammad Reza
    Sarmasti, Azar
    Hassanpour, Kamyab
    Akrami, Ali
    HELIYON, 2024, 10 (05)
  • [2] Clinical Antiviral Efficacy of Remdesivir in Coronavirus Disease 2019: An Open-Label, Randomized Controlled Adaptive Platform Trial (PLATCOV)
    Jittamala, Podjanee
    Schilling, William H. K.
    Watson, James A.
    Luvira, Viravarn
    Siripoon, Tanaya
    Ngamprasertchai, Thundon
    Almeida, Pedro J.
    Ekkapongpisit, Maneerat
    Cruz, Cintia
    Callery, James J.
    Boyd, Simon
    Anunsittichai, Orawan
    Hongsuwan, Maliwan
    Singhaboot, Yutatirat
    Pagornrat, Watcharee
    Tuntipaiboontana, Runch
    Kruabkontho, Varaporn
    Ngernseng, Thatsanun
    Tubprasert, Jaruwan
    Abdad, Mohammad Yazid
    Keayarsa, Srisuda
    Madmanee, Wanassanan
    Aguiar, Renato S.
    Santos, Franciele M.
    Batty, Elizabeth M.
    Hanboonkunupakarn, Pongtorn
    Hanboonkunupakarn, Borimas
    Sookprome, Sakol
    Poovorawan, Kittiyod
    Imwong, Mallika
    Taylor, Walter R. J.
    Chotivanich, Vasin
    Sangketchon, Chunlanee
    Ruksakul, Wiroj
    Chotivanich, Kesinee
    Pukrittayakamee, Sasithon
    Dondorp, Arjen M.
    Day, Nicholas P. J.
    Teixeira, Mauro M.
    Piyaphanee, Watcharapong
    Phumratanaprapin, Weerapong
    White, Nicholas J.
    JOURNAL OF INFECTIOUS DISEASES, 2023, 228 (10) : 1318 - 1325
  • [3] Effects of Losartan on Patients Hospitalized for Acute Coronavirus Disease 2019: A Randomized Controlled Trial
    Tran, Karen C.
    Asfar, Pierre
    Cheng, Matthew
    Demiselle, Julien
    Singer, Joel
    Lee, Terry
    Sweet, David
    Boyd, John
    Walley, Keith
    Haljan, Greg
    Sharif, Omar
    Geri, Guillaume
    Auchabie, Johann
    Quenot, Jean-Pierre
    Lee, Todd C.
    Tsang, Jennifer
    Meziani, Ferhat
    Lamontagne, Francois
    Dubee, Vincent
    Lasocki, Sigismond
    Ovakim, Daniel
    Wood, Gordon
    Turgeon, Alexis
    Cohen, Yves
    Lebas, Eddy
    Goudelin, Marine
    Forrest, David
    Teale, Alastair
    Mira, Jean-Paul
    Fowler, Robert
    Daneman, Nick
    Adhikari, Neill K. J.
    Gousseff, Marie
    Leroy, Pierre
    Plantefeve, Gaetan
    Rispal, Patrick
    Courtois, Roxane
    Winston, Brent
    Reynolds, Steve
    Birks, Peter
    Bienvenu, Boris
    Tadie, Jean-Marc
    Talarmin, Jean-Philippe
    Ansart, Severine
    Russell, James A.
    CLINICAL INFECTIOUS DISEASES, 2024, 79 (03) : 615 - 625
  • [4] Efficacy and Safety of Lianhuaqingwen Capsules for the Prevention of Coronavirus Disease 2019: A Prospective Open-Label Controlled Trial
    Gong, Xiaowei
    Yuan, Boyun
    Yuan, Yadong
    Li, Fengju
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2021, 2021
  • [5] Hyperimmune Globulin for Severely Immunocompromised Patients Hospitalized With Coronavirus Disease 2019: A Randomized, Controlled Trial
    Huygens, Sammy
    Hofsink, Quincy
    Nijhof, Inger S.
    Goorhuis, Abraham
    Kater, Arnon P.
    te Boekhorst, Peter A. W.
    Swaneveld, Francis
    Bogers, Susanne
    Welkers, Matthijs R. A.
    Papageorgiou, Grigorios
    Rijnders, Bart J.
    Heijmans, Jarom
    NovotnY, Vera M. J.
    JOURNAL OF INFECTIOUS DISEASES, 2023, 227 (02) : 206 - 210
  • [6] Effect of an inactivated coronavirus disease 2019 vaccine, CoronaVac, on blood coagulation and glucose: a randomized, controlled, open-label phase IV clinical trial
    Xu, Qing
    Lu, Xi
    Liu, Xiaodong
    Zhao, Yanwei
    Sun, Dapeng
    Cao, Qingfan
    Liu, Haidong
    Yang, Tuantuan
    Song, Yufei
    Lv, Jingjing
    Xiong, Ping
    Li, Jing
    Sun, Jianwen
    Xie, Meng
    Gao, Yongjun
    Zhang, Li
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [7] Randomized controlled trials of remdesivir in hospitalized coronavirus disease 2019 patients: A meta-analysis
    Sarfraz, Azza
    Sarfraz, Zouina
    Sanchez-Gonzalez, Marcos
    Michel, Jack
    Michel, George
    Frontela, Odalys
    Posada, Jorge
    Cardona, Jose
    Angueira, Eugenio
    TURKISH JOURNAL OF EMERGENCY MEDICINE, 2021, 21 (02): : 43 - 50
  • [8] Effectiveness and safety analysis of SanHanHuaShi granules for the treatment of coronavirus disease 2019: Study protocol and statistical analysis plan for a randomized, parallel-controlled, open-label clinical trial
    Liu, Yangyang
    Chen, Xi
    Wang, Hongan
    Yao, Chensi
    Gou, Xiaowen
    Gao, Zezheng
    Sun, Linlin
    Liu, Dan
    Tang, Cheng
    Wei, Yu
    Ding, Qiyou
    Yang, Haoyu
    Lin, Jiaran
    Chen, Keyu
    Chen, Jia
    Zhao, Linhua
    Li, Min
    Han, Lin
    Wang, Jian
    Ren, Jixiang
    Zhang, Ying
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [9] A Multi-Center, Open-Label, Randomized Controlled Trial to Evaluate the Efficacy of Convalescent Plasma Therapy for Coronavirus Disease 2019: A Trial Protocol (COVIPLA-RCT)
    Tomita, Noriko
    Saito, Sho
    Terada-Hirashima, Junko
    Mikami, Ayako
    Uemura, Yukari
    Kutsuna, Satoshi
    Nomoto, Hidetoshi
    Fujisawa, Kyoko
    Nagashima, Maki
    Terada, Mari
    Ashida, Shinobu
    Morioka, Shinichiro
    Satake, Masahiro
    Hangaishi, Akira
    Togano, Tomiteru
    Shiratori, Katsuyuki
    Takamatsu, Yuki
    Maeda, Kenji
    Ohmagari, Norio
    Sugiura, Wataru
    Mitsuya, Hiroaki
    LIFE-BASEL, 2022, 12 (06):
  • [10] Adding colchicine to tocilizumab in hospitalized patients with severe COVID-19 pneumonia: An open-label randomized controlled trial
    Rahhal, Alaa
    Najim, Mostafa
    Aljundi, Amer Hussein
    Mahfouz, Ahmed
    Alyafei, Sumaya Mehdar
    Awaisu, Ahmed
    Habib, Mhd Baraa
    Obeidat, Ibrahim
    Faisal, Mohanad Mohammed
    Alanzi, Meshaal Ali
    Nair, Arun Prabhakaran
    Elhassan, Areeg
    Al-Dushain, Abdullah
    Abdelmajid, Alaaeldin Abdelmajid
    Abdelgader, Ahmed Elfadil
    Moursi, Ahmed Mahmoud Ahmed
    Alharafsheh, Ahmad Eid Nazzal
    Abou Kamar, Mohd Ragheb
    Goravey, Wael
    Omar, Amr Salah
    Abukhattab, Mohammed
    Khatib, Mohamad Yahya
    Mohamedali, Mohamed Gaafar
    AlMaslamani, Muna A. Rahman
    Alemadi, Samar
    MEDICINE, 2022, 101 (39) : E30618